Chemours Sells Glycolic Acid Business to PureTech Scientific for $137M

The Chemours Company agreed to sell its Glycolic Acid business for $137 million in cash to PureTech Scientific Inc., backed by Iron Path Capital. The transaction is expected to close by Q3 2023.

“Creating a better world through the power of our chemistry requires a clear focus on where to play and how to win.”ironpathcapital.com

• 1 source
• ironpathcapital.comThe Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 MillionIron Path CapitalJun 1, 2023

Summarized from public sources; check the original articles before acting on it.